1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Parenteral (Subcutaneous Injection)
1.3 Market by Application
1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drug Store
1.3.3 Independent Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2017-2028)
2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Region
2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Opioid-Induced Constipation (OIC) Treatment Market Dynamics
2.3.1 Opioid-Induced Constipation (OIC) Treatment Industry Trends
2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers
2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges
2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue
3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2017-2022)
3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio
3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2021
3.5 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
3.6 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
3.7 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type
4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2023-2028) 5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application
5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2028)
6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
6.2.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2017-2022)
6.2.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2023-2028)
6.2.3 North America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2017-2028)
6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
6.3.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2017-2022)
6.3.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2023-2028)
6.3.3 North America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2017-2028)
6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
6.4.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2022)
6.4.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2028)
7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type
7.2.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2017-2028)
7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application
7.3.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2017-2028)
7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country
7.4.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type
8.2.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application
8.3.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region
8.4.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2028)
9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
9.2.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2017-2028)
9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
9.3.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2017-2028)
9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
9.4.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type
10.2.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application
10.3.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country
10.4.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction
11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.2.5 AstraZeneca Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction
11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 S.L.A. Pharma
11.4.1 S.L.A. Pharma Company Details
11.4.2 S.L.A. Pharma Business Overview
11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction
11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.4.5 S.L.A. Pharma Recent Developments
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Details
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.5.5 AIKO Biotechnology Recent Developments
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Company Details
11.6.2 Cubist Pharmaceuticals Business Overview
11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.6.5 Cubist Pharmaceuticals Recent Developments
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.7.5 Salix Pharmaceuticals Recent Developments
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2017-2022)
11.8.5 Takeda Pharmaceutical Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
